Detalles de la búsqueda
1.
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.
Br J Cancer
; 127(7): 1201-1213, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768550
2.
Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.
Radiology
; 296(2): 277-287, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452738
3.
Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.
PLoS Comput Biol
; 14(10): e1006520, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30379847
4.
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.
Breast Cancer Res
; 19(1): 99, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851423
5.
A multilevel pan-cancer map links gene mutations to cancer hallmarks.
Chin J Cancer
; 34(10): 439-49, 2015 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26369414
6.
Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.
Clin Cancer Res
; 29(18): 3729-3743, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449970
7.
Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.
Breast
; 60: 230-237, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763270
8.
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.
NPJ Breast Cancer
; 7(1): 31, 2021 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753731
9.
Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo.
Nat Commun
; 10(1): 5034, 2019 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31695042
10.
Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?
Eur J Radiol
; 121: 108705, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31655316
11.
Complementary Value of Contralateral Parenchymal Enhancement on DCE-MRI to Prognostic Models and Molecular Assays in High-risk ER+/HER2- Breast Cancer.
Clin Cancer Res
; 23(21): 6505-6515, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28790119
12.
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
Sci Rep
; 6: 18517, 2016 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26729235
13.
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.
Mol Oncol
; 9(8): 1528-38, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26004083
Resultados
1 -
13
de 13
1
Próxima >
>>